| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.004 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.092 | 0.005 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.098 | 0.005 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.006 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.008 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.14 | 0.009 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.15 | 0.01 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.17 | 0.01 |